Our Portfolio

Below companies have either been created by Forty51 Ventures or received their first financing from Forty51 Ventures as lead, or co-lead investor, in its first institutional financing.

Mosanna Therapeutics, Basel

2022

Metabolic Obstructive Sleep Apnea (First-in-Class)

Investment Number 2

2022

This investment is currently in process

Investment Number 3

2022

This investment is currently in process